CNP
67
4
RL
79
3
TXN
43
10
EQR
67
2
PNW
45
-4
UAL
38
4
RCL
66
4
LRCX
71
-6
IVZ
48
5
PFE
32
2
AVY
75
3
DOW
50
12
AAP
26
2
BBY
51
-2
MO
45
3
ACN
42
-16
EFX
66
11
XEL
51
3
MLM
61
-2
VZ
29
5
CNP
67
4
RL
79
3
TXN
43
10
EQR
67
2
PNW
45
-4
UAL
38
4
RCL
66
4
LRCX
71
-6
IVZ
48
5
PFE
32
2
AVY
75
3
DOW
50
12
AAP
26
2
BBY
51
-2
MO
45
3
ACN
42
-16
EFX
66
11
XEL
51
3
MLM
61
-2
VZ
29
5
Financhill
Back

Naas Technology Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
9

NAAS
Naas Technology

Last Price:
3.58
Seasonality Move:
-16.46%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
9
Naas Technology (NAAS) is a Sell

Is Naas Technology a Buy, Sell or Hold?

  • The current Naas Technology [NAAS] share price is $5.28. The Score for NAAS is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • NAAS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NAAS Stock Price Chart

What is Naas Technology's stock price today?

  • The Naas Technology share price today is $5.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NAAS is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

NAAS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.08 Sell
Relative Strength Index (14 RSI): 26.61 Sell
Chaikin Money Flow: -87032 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.07 - 9.11) Sell
Bollinger Bands (100): (11.1 - 29.68) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

NAAS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.02 Sell
20-day SMA: 7.13 Sell
50-day SMA: 12.8 Sell
200-day SMA: 511.03 Sell
8-day EMA: 6.05 Sell
20-day EMA: 7.59 Sell
50-day EMA: 19.89 Sell
200-day EMA: 564.09 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

Naas Technology Earnings Growth & NAAS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.54 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Naas Technology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):